Emergency pharmacy order for feiba vials for portland VAMC
Ended Awarded
- Contract number
- 36C26019N0283
- Awardee
-
Baxalta US Inc. UEI LT5GEHL2F1K6
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $75,839
Award facts
- Contract value 100% obligated
- $75,839.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Portland, OR 97239, USA
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order awarded by the Department of Veterans Affairs Veterans Integrated Service Network 20 to Baxalta US Inc., a foreign-owned for-profit pharmaceutical company, for the emergency procurement of FEIBA anti-inhibitor coagulant complex vials for the Portland VA Medical Center. The order was placed against Baxalta's existing GSA Pharmaceutical and Drugs Schedule contract and has a firm-fixed price ceiling value of $75,839.40. No set-aside designation was used for this award. Baxalta specializes in treatments for bleeding disorders, immunodeficiencies, and other rare chronic conditions, and has previously provided other specialty pharmaceuticals such as ADVATE for hemophilia and GAMMAGARD LIQUID immunoglobulin therapy to various federal agencies through its GSA schedule contract.
Quick answers
Who was awarded contract 36C26019N0283?
36C26019N0283 was awarded to Baxalta US Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on January 11, 2019.
How much is contract 36C26019N0283 worth?
The government has obligated $75,839 on 36C26019N0283.
Is contract 36C26019N0283 an order under another contract?
Yes. 36C26019N0283 is a delivery order under V797P2140D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26019N0283 competed?
The extent of competition for 36C26019N0283 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award